Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active (can be taken orally) and was developed for the treatment of influenza.
Against coronaviruses including SARS, MERS, SARS-CoV-2 and Covid19.
苏州正永生物医药有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
正永生物